Epidemiology and Survival Outcomes of Lung Cancer: A Population-Based Study
Table 6
Joinpoint analysis of lung cancer overall survivala by sex and Charlson Comorbidity Index (CCI) in Taiwan from 2002 to 2014.
Lung cancer survival rate
Average APC
Trend 1
Trend 2
2002
Endb
Years
APC (95% CI)
Years
APC (95% CI)
Total
1-year survival rate
37.81
(36.70–38.92)
57.39
(56.49–58.28)
3.60 (3.20–4.10)
2002 to 2014
3.60 (3.20–4.10)
3-year survival rate
14.66
(13.86–15.48)
29.55
(28.70–30.40)
7.50 (6.50–8.60)
2002 to 2012
7.50 (6.50–8.60)
5-year survival rate
9.37
(8.72–10.06)
17.34
(16.61–18.09)
9.30 (7.60–11.10)
2002 to 2010
9.30 (7.60–11.10)
Sex
Male
1-year survival rate
34.90
(33.55–36.22)
48.20
(47.01–49.36)
3.10 (2.70–3.50)
2002 to 2014
3.10 (2.70–3.50)
3-year survival rate
13.10
(12.13–14.02)
22.00
(20.99–22.97)
5.90 (4.60–7.30)
2002 to 2012
5.90 (4.60–7.30)
5-year survival rate
8.40
(7.67–9.22)
12.60
(11.82–13.46)
6.30 (4.00–8.60)
2002 to 2010
6.30 (4.00–8.60)
Female
1-year survival rate
43.70
(41.70–45.64)
70.60
(69.29–71.86)
4.10 (3.00–5.30)
2002 to 2007
6.30 (3.30–9.40)
2007 to 2014
2.60 (1.60–3.60)
3-year survival rate
17.90
(16.37–19.42)
41.10
(39.66–42.57)
8.10 (7.00–9.30)
2002 to 2012
8.10 (7.00–9.30)
5-year survival rate
11.30
(10.06–12.58)
25.40
(24.04–26.85)
11.80 (10.50–13.00)
2002 to 2010
11.80 (10.50–13.00)
CCI
CCI ≤ 1
1-year survival rate
42.40
(39.98–44.82)
69.80
(68.33–71.20)
4.00 (3.50–4.50)
2002 to 2014
4.00 (3.50–4.50)
3-year survival rate
17.70
(15.85–19.59)
39.20
(37.58–40.79)
8.60 (6.90–10.20)
2002 to 2012
8.60 (6.90–10.20)
5-year survival rate
11.40
(9.93–13.05)
24.50
(22.98–26.04)
11.30 (9.00–13.80)
2002 to 2010
11.30 (9.00–13.80)
CCI ≥ 2
1-year survival rate
36.50
(35.27–37.77)
51.20
(50.08–52.29)
3.10 (2.60–3.60)
2002 to 2014
3.10 (2.60–3.60)
3-year survival rate
13.80
(12.93–14.72)
25.00
(24.05–26.00)
6.40 (5.60–7.20)
2002 to 2012
6.40 (5.60–7.20)
5-year survival rate
8.80
(8.08–9.55)
14.30
(13.44–15.08)
7.40 (5.80–9.00)
2002 to 2010
7.40 (5.80–9.00)
APC, annual percent change; CCI, Charlson Comorbidity Index; .aOverall survival of patients with lung cancer was extracted from overall mortality rates in the National Death Registry of Taiwan, and the relative survival rates were estimated using the life table method. bThe end year in one-year survival is 2014, the end year in three-year survival is 2012, and the end year in five-year survival is 2010.
